Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy

Journal of Cataract and Refractive Surgery

Volumn 32, Issue 9, 2006, Pages 1499-1502

  Ünal, Mustafa ^a   Yücel, Iclal ^a   Akar, Yusuf ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; BRINZOLAMIDE;

ADULT; AGED; ARTICLE; CAPSULOTOMY; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; OCULOPLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CLONIDINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; LENS CAPSULE, CRYSTALLINE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES; SULFONAMIDES; THIAZINES; TONOMETRY, OCULAR;

EID: 33747359958     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2006.04.014     Document Type: Article

References (25)

1. Seong G.J., Lee Y.G., Lee J.H., et al. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy. Ophthalmic Surg Lasers 31 (2000) 308-314
2. Flohr M.J., Robin A.L., and Kelley J.S. Early complications following Q-switched neodymium:YAG laser posterior capsulotomy. Ophthalmology 92 (1985) 360-363
3. Channell M.M., and Beckman H. Intraocular pressure changes after neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 102 (1984) 1024-1026
4. Anand N., Tole D.M., and Morrell A.J. Effect of intraocular lens fixation on acute intraocular pressure rise after neodymium-YAG laser capsulotomy. Eye 10 (1996) 509-513
5. Pollack I.P., Brown R.H., Crandall A.S., et al. Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy. Trans Am Ophthalmol Soc 86 (1988) 461-469 discussion, 469-472
6. Chen T.C. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery. J Cataract Refract Surg 31 (2005) 1707-1712
7. Chen T.C., Ang R.T., Grosskreutz C.L., et al. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology 108 (2001) 1033-1038
8. DeSantis L. Preclinical overview of brinzolamide. Surv Ophthalmol 44 suppl 2 (2000) S119-S129
9. van der Valk R., Webers C.A.B., Schouten J.S.A.G., et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs; a meta-analysis of randomized clinical trials. Ophthalmology 112 (2005) 1177-1185
10. tm), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension; the Brinzolamide Primary Therapy Study Group. Am J Ophthalmol 126 (1998) 400-408
11. March W.F., and Ochsner K.I. The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group. Am J Ophthalmol 129 (2000) 136-143
12. Dayanir V., Özcura F., Kir E., et al. Medical control of intraocular pressure after phacoemulsification. J Cataract Refract Surg 31 (2005) 484-488
13. Ermis S.S., Ozturk F., and Inan U.U. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification. Eye 19 (2005) 303-307
14. Steinert R.F., Puliafito C.A., Kumar S.R., et al. Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol 112 (1991) 373-380
15. Chevrier R.L., Assalian A., Duperre J., and Lesk M.R. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. Ophthalmic Surg Lasers 30 (1999) 199-204
16. Ladas I.D., Baltatzis S., Panagiotidis D., et al. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy. Arch Ophthalmol 115 (1997) 1241-1244
17. Ladas I.D., Pavlopoulos G.P., Kokolakis S.N., and Theodossiadis G.P. Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy. Br J Ophthalmol 77 (1993) 136-138
18. Arieta C.E.L., Amaral M.S., Matuda E., et al. Dorzolamide × apraclonidine in the prevention of the intraocular pressure spike after Nd:YAG laser posterior capsulotomy. Curr Eye Res 25 (2002) 237-241
19. Kaufman P.F. Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans. [editorial]. Arch Ophthalmol 117 (1999) 673-674
20. Silverstone D.E., Novack G.D., Kelley E.P., and Chen K.S. Prophylactic treatment of intraocular pressure elevations after neodymium:YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol. Ophthalmology 95 (1988) 713-718
21. Mittra R.A., Allingham R.R., and Shields M.B. Follow-up of argon laser trabeculoplasty: is a day-one postoperative IOP check necessary?. Ophthalmic Surg Lasers 26 (1995) 410-413
22. Richter C.U., Arzeno G., Pappas H.R., et al. Intraocular pressure elevation following Nd:YAG laser posterior capsulotomy. Ophthalmology 92 (1985) 636-639 discussion by DF Gaasterland, 640
23. Pollack I.P., Brown R.H., Crandall A.S., et al. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol 106 (1988) 754-757
24. Cullom Jr. R.D., and Schwartz L.W. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy. Ophthalmic Surg 24 (1993) 623-626
25. Silverstone D.E., Brint S.F., Olander K.W., et al. Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies. Am J Ophthalmol 113 (1992) 401-405